KCT0008243
Recruiting
未知
Evaluation of efficacy and safety using Acellular Dermal Matrix as a Substitute for Middle Hepatic Vein Reconstruction During Living Donor Liver Transplantation, single-center, single-arm, prospective pilot study
ConditionsDiseases of the digestive system
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Diseases of the digestive system
- Sponsor
- Chungnam National University Hospital
- Enrollment
- 10
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Adults over 19 \~ 70 years old undergoing live liver transplant surgery using the right lobe of the modified liver
- •2\) GWRW \> 0\.8, MELE Score \< 20, Selected Patients from the Patient Group
Exclusion Criteria
- •1\) Patients with living liver transplantation using the left lobe of the liver
- •2\) Patients with living liver transplant using extended right lobe (when MHV reconstruction is not required)
- •3\) If the right lobe starch section of the liver is dominant and the flow of the reconstructed middle vein is blocked, the patient's
- •If it is expected to have a prognosis
- •4\) Those who cannot perform both liver CT or liver Doppler tests
- •5\) Those who are judged unsuitable to participate in this clinical trial by other researchers
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Safety and Efficacy check of Cosmetic Product on skiCTRI/2024/01/061433KAYA LIMITED
Not yet recruiting
Not Applicable
Efficacy check of skin care productCTRI/2023/12/060574SATIYA NUTRACEUTICALS PRIVATE LIMITED
Completed
Not Applicable
Safety and efficacy assessment of Product on skiCTRI/2023/02/049933HONASA CONSUMER PVT LTD. (MAMAEARTH)38
Completed
Not Applicable
Safety and Efficacy assessment of Cosmetic Product on skiCTRI/2023/02/049645Ajanta Pharma Ltd35
Completed
Not Applicable
Safety & efficacy assessment of products on skiCTRI/2019/08/020708Alembic Pharmaceuticals Ltd34